Verastem Oncology (Nasdaq: VSTM), a biopharmaceutical company committed to advancing new medicines for patients with RAS/MAPK ...

After an extremely challenging period, Sandor and Erika Nagy have said they are "determined to keep living, creating and ...

Despite the physical and mental battles, and constant medical appointments, Sandor, 44, and Erika, 54, say they are ...

The guideline authors used data from 61 studies to provide recommendations on the use of neoadjuvant chemotherapy in patients with newly diagnosed, stage III-IV epithelial ovarian, fallopian tube, or ...

ASCO Guidelines follow the ASCO Conflict of Interest Policy for Clinical Practice Guidelines. To provide updated guidance regarding neoadjuvant chemotherapy (NACT) and primary cytoreductive surgery ...

Ovarian cancer continues to pose a significant challenge in the medical field, remaining one of the leading causes of death ...